G-CSF drives a posttraumatic immune program that protects the host from infection

Journal of Immunology

Volumn 192, Issue 5, 2014, Pages 2405-2417

  Gardner, Jason C ^a   Noel, John G ^b   Nikolaidis, Nikolaos M ^a   Karns, Rebekah ^c   Aronow, Bruce J ^c   Ogle, Cora K ^a   McCormack, Francis X ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b SHRINERS HOSPITALS FOR CHILDREN   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 6; STAT3 PROTEIN;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CELL ACTIVATION; CELL COMPARTMENTALIZATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; GENE EXPRESSION; HEMATOPOIESIS; HOST RESISTANCE; INNATE IMMUNITY; KLEBSIELLA PNEUMONIAE INFECTION; LUNG INFECTION; MOUSE; NEUTROPHILIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RESPIRATORY BURST; THERMAL INJURY;

ADAPTIVE IMMUNITY; ANIMALS; BONE MARROW CELLS; BURNS; GRANULOCYTE COLONY-STIMULATING FACTOR; IMMUNITY, INNATE; INTERLEUKIN-6; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICE; NEUTROPHILS; PNEUMONIA, BACTERIAL; STAT3 TRANSCRIPTION FACTOR;

EID: 84896515096     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302752     Document Type: Article

References (73)

1. Xiao, W., M. N. Mindrinos, J. Seok, J. Cuschieri, A. G. Cuenca, H. Gao, D. L. Hayden, L. Hennessy, E. E. Moore, J. P. Minei, et al; Inflammation and Host Response to Injury Large-Scale Collaborative Research Program. 2011. A genomic storm in critically injured humans. J. Exp. Med. 208: 2581-2590.
2. Paterson, H. M., T. J. Murphy, E. J. Purcell, O. Shelley, S. J. Kriynovich, E. Lien, J. A. Mannick, and J. A. Lederer. 2003. Injury primes the innate immune system for enhanced Toll-like receptor reactivity. J. Immunol. 171: 1473-1483.
3. Murphy, T. J., H. M. Paterson, S. Kriynovich, Y. Zang, E. A. Kurt-Jones, J. A. Mannick, and J. A. Lederer. 2005. Linking the "two-hit" response following injury to enhanced TLR4 reactivity. J. Leukoc. Biol. 77: 16-23.
4. Oppeltz, R. F., M. Rani, Q. Zhang, and M. G. Schwacha. 2011. Burn-induced alterations in toll-like receptor-mediated responses by bronchoalveolar lavage cells. Cytokine 55: 396-401.
5. Maung, A. A., S. Fujimi, M. L. Miller, M. P. MacConmara, J. A. Mannick, and J. A. Lederer. 2005. Enhanced TLR4 reactivity following injury is mediated by increased p38 activation. J. Leukoc. Biol. 78: 565-573.
6. Kasten, K. R., H. S. Goetzman, M. R. Reid, A. M. Rasper, S. G. Adediran, C. T. Robinson, C. M. Cave, J. S. Solomkin, A. B. Lentsch, J. A. Johannigman, and C. C. Caldwell. 2010. Divergent adaptive and innate immunological responses are observed in humans following blunt trauma. BMC Immunol. 11: 4.
7. Hietbrink, F., L. Koenderman, G. Rijkers, and L. Leenen. 2006. Trauma: the role of the innate immune system. World J. Emerg. Surg. 1: 15.
8. Maung, A. A., S. Fujimi, M. P. MacConmara, G. Tajima, A. M. McKenna, A. J. Delisle, C. Stallwood, A. B. Onderdonk, J. A. Mannick, and J. A. Lederer. 2008. Injury enhances resistance to Escherichia coli infection by boosting innate immune system function. J. Immunol. 180: 2450-2458.
9. Alexander, J. W. 1968. Effect of thermal injury upon the early resistance to infection. J. Surg. Res. 8: 128-137.
10. Noel, G., Q. Wang, A. Osterburg, S. Schwemberger, L. James, L. Haar, N. Giacalone, I. Thomas, and C. Ogle. 2010. A ribonucleotide reductase inhibitor reverses burn-induced inflammatory defects. Shock 34: 535-544.
11. Stieritz, D. D., and I. A. Holder. 1975. Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: description of a burned mouse model. J. Infect. Dis. 131: 688-691.
12. Pinto, M., and T. Zehavi-Willner. 1989. Thermal injury-induced non-specific resistance to fatal Pseudomonas aeruginosa burn-infection in mice. Jpn. J. Exp. Med. 59: 189-196.
13. Chambler, K., and J. R. Batchelor. 1969. Influence of defined incompatibilities and area of burn on skin-homograft survival in burned-subjects. Lancet 1: 16-18.
14. Munster, A. M., K. Eurenius, R. M. Katz, L. Canales, F. D. Foley, and R. F. Mortensen. 1973. Cell-mediated immunity after thermal injury. Ann. Surg. 177: 139-143.
15. Duan, X., D. Yarmush, A. Leeder, M. L. Yarmush, and R. N. Mitchell. 2008. Burn-induced immunosuppression: attenuated T cell signaling independent of IFN-gamma-And nitric oxide-mediated pathways. J. Leukoc. Biol. 83: 305-313.
16. Patenaude, J., M. D'Elia, C. Hamelin, D. Garrel, and J. Bernier. 2005. Burn injury induces a change in T cell homeostasis affecting preferentially CD4+ T cells. J. Leukoc. Biol. 77: 141-150.
17. Tschöp, J., A. Martignoni, M. D. Reid, S. G. Adediran, J. Gardner, G. J. Noel, C. K. Ogle, A. N. Neely, and C. C. Caldwell. 2009. Differential immunological phenotypes are exhibited after scald and flame burns. Shock 31: 157-163.
18. Deitch, E. A., D. Z. Xu, and L. Qi. 1990. Different lymphocyte compartments respond differently to mitogenic stimulation after thermal injury. Ann. Surg. 211: 72-77.
19. O'Riordain, D. S., M. V. Mendez, R. G. Holzheimer, K. Collins, J. A. Mannick, and M. L. Rodrick. 1995. Interleukin-2 receptor expression and function following thermal injury. Arch. Surg. 130: 165-170.
20. Toliver-Kinsky, T. E., T. K. Varma, C. Y. Lin, D. N. Herndon, and E. R. Sherwood. 2002. Interferon-gamma production is suppressed in thermally injured mice: decreased production of regulatory cytokines and corresponding receptors. Shock 18: 322-330.
21. O'Sullivan, S. T., J. A. Lederer, A. F. Horgan, D. H. Chin, J. A. Mannick, and M. L. Rodrick. 1995. Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann. Surg. 222: 482-490; discussion 490-482.
22. MacConmara, M. P., A. A. Maung, S. Fujimi, A. M. McKenna, A. Delisle, P. H. Lapchak, S. Rogers, J. A. Lederer, and J. A. Mannick. 2006. Increased CD4 + CD25+ T regulatory cell activity in trauma patients depresses protective Th1 immunity. Ann. Surg. 244: 514-523.
23. MacConmara, M. P., G. Tajima, F. O'Leary, A. J. Delisle, A. M. McKenna, C. G. Stallwood, J. A. Mannick, and J. A. Lederer. 2011. Regulatory T cells suppress antigen-driven CD4 T cell reactivity following injury. J. Leukoc. Biol. 89: 137-147.
24. Livingston, D. H., D. Anjaria, J. Wu, C. J. Hauser, V. Chang, E. A. Deitch, and P. Rameshwar. 2003. Bone marrow failure following severe injury in humans. Ann. Surg. 238: 748-753.
25. Posluszny, J. A., Jr., K. Muthumalaiappan, A. R. Kini, A. Szilagyi, L. K. He, Y. Li, R. L. Gamelli, and R. Shankar. 2011. Burn injury dampens erythroid cell production through reprioritizing bone marrow hematopoietic response. J. Trauma 71: 1288-1296.
26. Still, J. M., Jr., K. Belcher, E. J. Law, W. Thompson, M. Jordan, M. Lewis, J. Saffle, J. Hunt, G. F. Purdue, J. P. Waymack, et al. 1995. A double-blinded prospective evaluation of recombinant human erythropoietin in acutely burned patients. J. Trauma 38: 233-236.
27. Posluszny, J. A., Jr., P. Conrad, M. Halerz, R. Shankar, and R. L. Gamelli. 2011. Classifying transfusions related to the anemia of critical illness in burn patients. J. Trauma 71: 26-31.
28. Neely, A. N., D. L. Hoover, I. A. Holder, and A. S. Cross. 1996. Circulating levels of tumour necrosis factor, interleukin 6 and proteolytic activity in a murine model of burn and infection. Burns 22: 524-530.
29. Domenico, P., D. L. Diedrich, and D. C. Straus. 1985. Extracellular polysaccharide production by Klebsiella pneumoniae and its relationship to virulence. Can. J. Microbiol. 31: 472-478.
30. Wei, R. Q., J. B. Yee, D. C. Straus, and J. C. Hutson. 1988. Bactericidal activity of testicular macrophages. Biol. Reprod. 38: 830-835.
31. Krutzik, P. O., M. R. Clutter, and G. P. Nolan. 2005. Coordinate analysis of murine immune cell surface markers and intracellular phosphoproteins by flow cytometry. J. Immunol. 175: 2357-2365.
32. Tung, J. W., K. Heydari, R. Tirouvanziam, B. Sahaf, D. R. Parks, L. A. Herzenberg, and L. A. Herzenberg. 2007. Modern flow cytometry: a practical approach. Clin. Lab. Med. 27: 453-468
33. Van Eeden, S. F., M. E. Klut, B. A.Walker, and J. C. Hogg. 1999. The use of flow cytometry to measure neutrophil function. J. Immunol. Methods 232: 23-43.
34. Chakraborty, A., and D. J. Tweardy. 1998. Stat3 and G-CSF-induced myeloid differentiation. Leuk. Lymphoma 30: 433-442.
35. Maeda, K., A. Malykhin, B. N. Teague-Weber, X. H. Sun, A. D. Farris, and K. M. Coggeshall. 2009. Interleukin-6 aborts lymphopoiesis and elevates production of myeloid cells in systemic lupus erythematosus-prone B6.Sle1.Yaa animals. Blood 113: 4534-4540.
36. Nicola, N. A., C. G. Begley, and D. Metcalf. 1985. Identification of the human analogue of a regulator that induces differentiation in murine leukaemic cells. Nature 314: 625-628.
37. Buzzeo, M. P., J. Yang, G. Casella, and V. Reddy. 2007. Hematopoietic stem cell mobilization with G-CSF induces innate inflammation yet suppresses adaptive immune gene expression as revealed by microarray analysis. Exp. Hematol. 35: 1456-1465.
38. Tian, S. S., P. Tapley, C. Sincich, R. B. Stein, J. Rosen, and P. Lamb. 1996. Multiple signaling pathways induced by granulocyte colony-stimulating factor involving activation of JAKs, STAT5, and/or STAT3 are required for regulation of three distinct classes of immediate early genes. Blood 88: 4435-4444.
39. Panopoulos, A. D., L. Zhang, J. W. Snow, D. M. Jones, A. M. Smith, K. C. El Kasmi, F. Liu, M. A. Goldsmith, D. C. Link, P. J. Murray, and S. S. Watowich. 2006. STAT3 governs distinct pathways in emergency granulopoiesis and mature neutrophils. Blood 108: 3682-3690.
40. Zhang, H., H. Nguyen-Jackson, A. D. Panopoulos, H. S. Li, P. J. Murray, and S. S. Watowich. 2010. STAT3 controls myeloid progenitor growth during emergency granulopoiesis. Blood 116: 2462-2471.
41. Nguyen-Jackson, H., A. D. Panopoulos, H. Zhang, H. S. Li, and S. S. Watowich. 2010. STAT3 controls the neutrophil migratory response to CXCR2 ligands by direct activation of G-CSF-induced CXCR2 expression and via modulation of CXCR2 signal transduction. Blood 115: 3354-3363.
42. Gabrilovich, D. I., and S. Nagaraj. 2009. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9: 162-174.
43. Noel, J. G., A. Osterburg, Q. Wang, X. Guo, D. Byrum, S. Schwemberger, H. Goetzman, C. C. Caldwell, C. K. Ogle. 2007. Thermal injury elevates the inflammatory monocyte subpopulation in multiple compartments. Shock. 28: 684-693.
44. Noel, G., Q. Wang, S. Schwemberger, C. Hanson, N. Giacalone, L. Haar, and C. K. Ogle. 2011. Neutrophils, not monocyte/macrophages, are the major splenic source of postburn IL-10. Shock 36: 149-155.
45. Cuenca, A. G., M. J. Delano, K. M. Kelly-Scumpia, C. Moreno, P. O. Scumpia, D. M. Laface, P. G. Heyworth, P. A. Efron, and L. L. Moldawer. 2011. A paradoxical role for myeloid-derived suppressor cells in sepsis and trauma. Mol. Med. 17: 281-292.
46. Munster, A. M., G. R. Gale, and H. H. Hunt. 1977. Accelerated tumor growth following experimental burns. J. Trauma 17: 373-375.
47. Ikeuchi, S., N. Aikawa, M. Okuda, K. Ishibiki, and O. Abe. 1981. Changes in cell-mediated immunity and tumour growth after thermal injury. Burns 7: 400-408.
48. Waight, J. D., Q. Hu, A. Miller, S. Liu, and S. I. Abrams. 2011. Tumor-derived G-CSF facilitates neoplastic growth through a granulocytic myeloid-derived suppressor cell-dependent mechanism. PLoS ONE 6: e27690.
49. Cook, K. M., Z. C. Sifri, G. M. Baranski, A. M. Mohr, and D. H. Livingston. 2013. The role of plasma granulocyte colony stimulating factor and bone marrow dysfunction after severe trauma. J. Am. Coll. Surg. 216: 57-64.
50. Lord, B. I., G. Molineux, Z. Pojda, L. M. Souza, J. J. Mermod, and T. M. Dexter. 1991. Myeloid cell kinetics in mice treated with recombinant interleukin-3, granulocyte colony-stimulating factor (CSF), or granulocyte-macrophage CSF in vivo. Blood 77: 2154-2159.
51. Kraft, R., D. N. Herndon, A. M. Al-Mousawi, F. N. Williams, C. C. Finnerty, and M. G. Jeschke. 2012. Burn size and survival probability in paediatric patients in modern burn care: a prospective observational cohort study. Lancet 379: 1013-1021.
52. Walker, F., H. H. Zhang, V. Matthews, J. Weinstock, E. C. Nice, M. Ernst, S. Rose-John, and A. W. Burgess. 2008. IL6/sIL6R complex contributes to emergency granulopoietic responses in G-CSF-And GM-CSF-deficient mice. Blood 111: 3978-3985.
53. Chou, D. B., B. Sworder, N. Bouladoux, C. N. Roy, A. M. Uchida, M. Grigg, P. G. Robey, and Y. Belkaid. 2012. Stromal-derived IL-6 alters the balance of myeloerythroid progenitors during Toxoplasma gondii infection. J. Leukoc. Biol. 92: 123-131.
54. Winkler, I. G., L. J. Bendall, C. E. Forristal, F. Helwani, B. Nowlan, V. Barbier, Y. Shen, A. Cisterne, L. M. Sedger, and J. P. Levesque. 2013. B-lymphopoiesis is stopped by mobilizing doses of G-CSF and is rescued by overexpression of the anti-Apoptotic protein Bcl2. Haematologica 98: 325-333.
55. Yan, B., J. J. Wei, Y. Yuan, R. Sun, D. Li, J. Luo, S. J. Liao, Y. H. Zhou, Y. Shu, Q. Wang, et al. 2013. IL-6 cooperates with G-CSF to induce protumor function of neutrophils in bone marrow by enhancing STAT3 activation. J. Immunol. 190: 5882-5893.
56. Sander, L. E., S. D. Sackett, U. Dierssen, N. Beraza, R. P. Linke, M. Müller, J. M. Blander, F. Tacke, and C. Trautwein. 2010. Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function. J. Exp. Med. 207: 1453-1464.
57. Quinton, L. J., M. T. Blahna, M. R. Jones, E. Allen, J. D. Ferrari, K. L. Hilliard, X. Zhang, V. Sabharwal, H. Algül, S. Akira, et al. 2012. Hepatocyte-specific mutation of both NF-kB RelA and STAT3 abrogates the acute phase response in mice. J. Clin. Invest. 122: 1758-1763.
58. Nemeth, E., S. Rivera, V. Gabayan, C. Keller, S. Taudorf, B. K. Pedersen, and T. Ganz. 2004. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J. Clin. Invest. 113: 1271-1276.
59. Deitch, E. A., and K. M. Sittig. 1993. A serial study of the erythropoietic response to thermal injury. Ann. Surg. 217: 293-299.
60. Roilides, E., T. J. Walsh, P. A. Pizzo, and M. Rubin. 1991. Granulocyte colonystimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils. J. Infect. Dis. 163: 579-583.
61. Falanga, A., M. Marchetti, V. Evangelista, S. Manarini, E. Oldani, S. Giovanelli, M. Galbusera, C. Cerletti, and T. Barbui. 1999. Neutrophil activation and hemostatic changes in healthy donors receiving granulocyte colony-stimulating factor. Blood 93: 2506-2514.
62. Allen, R. C., P. R. Stevens, T. H. Price, G. S. Chatta, and D. C. Dale. 1997. In vivo effects of recombinant human granulocyte colony-stimulating factor on neutrophil oxidative functions in normal human volunteers. J. Infect. Dis. 175: 1184-1192.
63. Rutella, S., F. Zavala, S. Danese, H. Kared, and G. Leone. 2005. Granulocyte colony-stimulating factor: a novel mediator of T cell tolerance. J. Immunol. 175: 7085-7091.
64. Franzke, A. 2006. The role of G-CSF in adaptive immunity. Cytokine Growth Factor Rev. 17: 235-244.
65. Sloand, E. M., S. Kim, J. P. Maciejewski, F. Van Rhee, A. Chaudhuri, J. Barrett, and N. S. Young. 2000. Pharmacologic doses of granulocyte colony-stimulating factor affect cytokine production by lymphocytes in vitro and in vivo. Blood 95: 2269-2274.
66. Franzke, A., W. Piao, J. Lauber, P. Gatzlaff, C. Könecke, W. Hansen, A. Schmitt-Thomsen, B. Hertenstein, J. Buer, and A. Ganser. 2003. G-CSF as immune regulator in T cells expressing the G-CSF receptor: implications for transplantation and autoimmune diseases. Blood 102: 734-739.
67. Pan, L., J. Delmonte, Jr., C. K. Jalonen, and J. L. Ferrara. 1995. Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease. Blood 86: 4422-4429.
68. Zou, L., B. Barnett, H. Safah, V. F. Larussa, M. Evdemon-Hogan, P. Mottram, S. Wei, O. David, T. J. Curiel, and W. Zou. 2004. Bone marrow is a reservoir for CD4+CD25+ regulatory T cells that traffic through CXCL12/CXCR4 signals. Cancer Res. 64: 8451-8455.
69. Cheng, A. C., D. P. Stephens, and B. J. Currie. 2007. Granulocyte-colony stimulating factor (G-CSF) as an adjunct to antibiotics in the treatment of pneumonia in adults. Cochrane Database Syst. Rev. (2):CD004400.
70. Marshall, J. C. 2005. The effects of granulocyte colony-stimulating factor in preclinical models of infection and acute inflammation. Shock 24(Suppl. 1): 120-129.
71. Held, T. K., M. E. Mielke, M. Chedid, M. Unger, M. Trautmann, D. Huhn, and A. S. Cross. 1998. Granulocyte colony-stimulating factor worsens the outcome of experimental Klebsiella pneumoniae pneumonia through direct interaction with the bacteria. Blood 91: 2525-2535.
72. Karzai, W., B. U. von Specht, C. Parent, J. Haberstroh, K. Wollersen, C. Natanson, S. M. Banks, and P. Q. Eichacker. 1999. G-CSF during Escherichia coli versus Staphylococcus aureus pneumonia in rats has fundamentally different and opposite effects. Am. J. Respir. Crit. Care Med. 159: 1377-1382.
73. Seok, J., H. S. Warren, A. G. Cuenca, M. N. Mindrinos, H. V. Baker, W. Xu, D. R. Richards, G. P. McDonald-Smith, H. Gao, L. Hennessy, et al; Inflammation and Host Response to Injury, Large Scale Collaborative Research Program. 2013. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc. Natl. Acad. Sci. USA 110: 3507-3512.